Loading…

CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis

Background Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries. Investigation of the underlying molecular mechanisms of PCa is urgently needed in order to develop better therapeutic strategies and to reveal more effective therapeutic targe...

Full description

Saved in:
Bibliographic Details
Published in:Prostate cancer and prostatic diseases 2021-09, Vol.24 (3), p.891-902
Main Authors: Capik, Ozel, Sanli, Fatma, Kurt, Ali, Ceylan, Onur, Suer, Ilknur, Kaya, Murat, Ittmann, Michael, Karatas, Omer Faruk
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653
cites cdi_FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653
container_end_page 902
container_issue 3
container_start_page 891
container_title Prostate cancer and prostatic diseases
container_volume 24
creator Capik, Ozel
Sanli, Fatma
Kurt, Ali
Ceylan, Onur
Suer, Ilknur
Kaya, Murat
Ittmann, Michael
Karatas, Omer Faruk
description Background Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries. Investigation of the underlying molecular mechanisms of PCa is urgently needed in order to develop better therapeutic strategies and to reveal more effective therapeutic targets. In this study, we aimed at exploring the potential functions of CASC11 in association with miR-145 and IGF1R during the malignant progression of PCa cells. Methods We initially investigated the oncogenic potential of noncoding members of CASC gene family and analyzed the effects of CASC11 overexpression on proliferation, migration, and colony formation ability of DU145, LNCaP, and PC3 PCa cells. We, then, exprlored the association of CASC11, miR-145, and IGF1R expression and their impacts on PI3K/AKT/mTOR signaling pathway in in vitro models. Results In silico analysis revealed that of the CASC family only CASC11 showed consistent results considering its differential expression as well as its association with the overall survival of patients. We demonstrated that ectopic overexpression of CASC11 significantly increased the proliferation, colony formation, and migration capacity in all three cell lines. CASC11 overexpression caused suppression of miR-145 and overexpression of IGF1R, leading to activation of PI3K/AKT/mTOR signaling pathway. Conclusion In summary, we found that CASC11 is upregulated in PCa cells and clinical tumor samples in comparison to corresponding controls and revealed that ectopic CASC11 overexpression promotes cellular phenotypes associated with PCa progression through CASC11/miR-145/IGF1R axis.
doi_str_mv 10.1038/s41391-021-00353-0
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2504351979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A673073115</galeid><sourcerecordid>A673073115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653</originalsourceid><addsrcrecordid>eNp9kVFrFDEQx4Motla_gA-yIEhftk0ym2T38TjaWigIV30O2dzsXsrupiZZsd_ebK9aK1LCkJD5_Scz-RPyntETRqE-jRWDhpWU56AgoKQvyCGrlCyFpPXLfAYpSlULfkDexHhDKW1YQ1-TAwAloFbikGzWq-s1Y8Vt8KNPGAvT9wFjdD9wylvhuyUVk0lYWDNZDIXFYYhF2gU_97tidJuSVeL08uKcbQrz08W35FVnhojvHvYj8u387Ov6c3n15eJyvboqbaUglWDstutaqbiyqqFSIDWi2lojWYeGC-DKmFrVtuUM27bFmuVAnmdrmJQCjsjxvm5u8PuMMenRxaU5M6Gfo-aCViBYo5qMfvwHvfFzmHJ3mZLQgKygfqR6M6B2U-dTMHYpqldSAVXA2PLsyX-ovLY4Ousn7Fy-fyL49Jdgh2ZIu-iHOTk_xacg34M2_3gM2Onb4EYT7jSjenFc7x3X2XF977imWfThYbS5HXH7R_Lb4gzAHog5NfUYHmd_puwvuvCxrw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2563936438</pqid></control><display><type>article</type><title>CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis</title><source>Springer Nature</source><creator>Capik, Ozel ; Sanli, Fatma ; Kurt, Ali ; Ceylan, Onur ; Suer, Ilknur ; Kaya, Murat ; Ittmann, Michael ; Karatas, Omer Faruk</creator><creatorcontrib>Capik, Ozel ; Sanli, Fatma ; Kurt, Ali ; Ceylan, Onur ; Suer, Ilknur ; Kaya, Murat ; Ittmann, Michael ; Karatas, Omer Faruk</creatorcontrib><description>Background Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries. Investigation of the underlying molecular mechanisms of PCa is urgently needed in order to develop better therapeutic strategies and to reveal more effective therapeutic targets. In this study, we aimed at exploring the potential functions of CASC11 in association with miR-145 and IGF1R during the malignant progression of PCa cells. Methods We initially investigated the oncogenic potential of noncoding members of CASC gene family and analyzed the effects of CASC11 overexpression on proliferation, migration, and colony formation ability of DU145, LNCaP, and PC3 PCa cells. We, then, exprlored the association of CASC11, miR-145, and IGF1R expression and their impacts on PI3K/AKT/mTOR signaling pathway in in vitro models. Results In silico analysis revealed that of the CASC family only CASC11 showed consistent results considering its differential expression as well as its association with the overall survival of patients. We demonstrated that ectopic overexpression of CASC11 significantly increased the proliferation, colony formation, and migration capacity in all three cell lines. CASC11 overexpression caused suppression of miR-145 and overexpression of IGF1R, leading to activation of PI3K/AKT/mTOR signaling pathway. Conclusion In summary, we found that CASC11 is upregulated in PCa cells and clinical tumor samples in comparison to corresponding controls and revealed that ectopic CASC11 overexpression promotes cellular phenotypes associated with PCa progression through CASC11/miR-145/IGF1R axis.</description><identifier>ISSN: 1365-7852</identifier><identifier>EISSN: 1476-5608</identifier><identifier>DOI: 10.1038/s41391-021-00353-0</identifier><identifier>PMID: 33753875</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>1-Phosphatidylinositol 3-kinase ; 13/106 ; 38/1 ; 38/109 ; 631/67/68 ; 692/699/67/68 ; 82 ; 82/80 ; 96 ; 96/63 ; AKT protein ; Analysis ; Apoptosis ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Cell Proliferation ; Colonies ; Developed countries ; Development and progression ; Gene Expression Regulation, Neoplastic ; Genes ; Health aspects ; Humans ; Lung cancer ; Male ; Malignancy ; MicroRNAs - genetics ; Molecular modelling ; Phenotypes ; Prognosis ; Prostate cancer ; Prostatic Neoplasms - genetics ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Receptor, IGF Type 1 - genetics ; Receptor, IGF Type 1 - metabolism ; Reproductive Medicine ; RNA, Long Noncoding - genetics ; Signal transduction ; Signaling ; Therapeutic targets ; TOR protein ; Tumor Cells, Cultured</subject><ispartof>Prostate cancer and prostatic diseases, 2021-09, Vol.24 (3), p.891-902</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Nature Limited.</rights><rights>COPYRIGHT 2021 Nature Publishing Group</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653</citedby><cites>FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653</cites><orcidid>0000-0002-0379-2088 ; 0000-0003-4802-0978</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33753875$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Capik, Ozel</creatorcontrib><creatorcontrib>Sanli, Fatma</creatorcontrib><creatorcontrib>Kurt, Ali</creatorcontrib><creatorcontrib>Ceylan, Onur</creatorcontrib><creatorcontrib>Suer, Ilknur</creatorcontrib><creatorcontrib>Kaya, Murat</creatorcontrib><creatorcontrib>Ittmann, Michael</creatorcontrib><creatorcontrib>Karatas, Omer Faruk</creatorcontrib><title>CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis</title><title>Prostate cancer and prostatic diseases</title><addtitle>Prostate Cancer Prostatic Dis</addtitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><description>Background Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries. Investigation of the underlying molecular mechanisms of PCa is urgently needed in order to develop better therapeutic strategies and to reveal more effective therapeutic targets. In this study, we aimed at exploring the potential functions of CASC11 in association with miR-145 and IGF1R during the malignant progression of PCa cells. Methods We initially investigated the oncogenic potential of noncoding members of CASC gene family and analyzed the effects of CASC11 overexpression on proliferation, migration, and colony formation ability of DU145, LNCaP, and PC3 PCa cells. We, then, exprlored the association of CASC11, miR-145, and IGF1R expression and their impacts on PI3K/AKT/mTOR signaling pathway in in vitro models. Results In silico analysis revealed that of the CASC family only CASC11 showed consistent results considering its differential expression as well as its association with the overall survival of patients. We demonstrated that ectopic overexpression of CASC11 significantly increased the proliferation, colony formation, and migration capacity in all three cell lines. CASC11 overexpression caused suppression of miR-145 and overexpression of IGF1R, leading to activation of PI3K/AKT/mTOR signaling pathway. Conclusion In summary, we found that CASC11 is upregulated in PCa cells and clinical tumor samples in comparison to corresponding controls and revealed that ectopic CASC11 overexpression promotes cellular phenotypes associated with PCa progression through CASC11/miR-145/IGF1R axis.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>13/106</subject><subject>38/1</subject><subject>38/109</subject><subject>631/67/68</subject><subject>692/699/67/68</subject><subject>82</subject><subject>82/80</subject><subject>96</subject><subject>96/63</subject><subject>AKT protein</subject><subject>Analysis</subject><subject>Apoptosis</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Cell Proliferation</subject><subject>Colonies</subject><subject>Developed countries</subject><subject>Development and progression</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Genes</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Male</subject><subject>Malignancy</subject><subject>MicroRNAs - genetics</subject><subject>Molecular modelling</subject><subject>Phenotypes</subject><subject>Prognosis</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Receptor, IGF Type 1 - genetics</subject><subject>Receptor, IGF Type 1 - metabolism</subject><subject>Reproductive Medicine</subject><subject>RNA, Long Noncoding - genetics</subject><subject>Signal transduction</subject><subject>Signaling</subject><subject>Therapeutic targets</subject><subject>TOR protein</subject><subject>Tumor Cells, Cultured</subject><issn>1365-7852</issn><issn>1476-5608</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kVFrFDEQx4Motla_gA-yIEhftk0ym2T38TjaWigIV30O2dzsXsrupiZZsd_ebK9aK1LCkJD5_Scz-RPyntETRqE-jRWDhpWU56AgoKQvyCGrlCyFpPXLfAYpSlULfkDexHhDKW1YQ1-TAwAloFbikGzWq-s1Y8Vt8KNPGAvT9wFjdD9wylvhuyUVk0lYWDNZDIXFYYhF2gU_97tidJuSVeL08uKcbQrz08W35FVnhojvHvYj8u387Ov6c3n15eJyvboqbaUglWDstutaqbiyqqFSIDWi2lojWYeGC-DKmFrVtuUM27bFmuVAnmdrmJQCjsjxvm5u8PuMMenRxaU5M6Gfo-aCViBYo5qMfvwHvfFzmHJ3mZLQgKygfqR6M6B2U-dTMHYpqldSAVXA2PLsyX-ovLY4Ousn7Fy-fyL49Jdgh2ZIu-iHOTk_xacg34M2_3gM2Onb4EYT7jSjenFc7x3X2XF977imWfThYbS5HXH7R_Lb4gzAHog5NfUYHmd_puwvuvCxrw</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Capik, Ozel</creator><creator>Sanli, Fatma</creator><creator>Kurt, Ali</creator><creator>Ceylan, Onur</creator><creator>Suer, Ilknur</creator><creator>Kaya, Murat</creator><creator>Ittmann, Michael</creator><creator>Karatas, Omer Faruk</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0379-2088</orcidid><orcidid>https://orcid.org/0000-0003-4802-0978</orcidid></search><sort><creationdate>20210901</creationdate><title>CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis</title><author>Capik, Ozel ; Sanli, Fatma ; Kurt, Ali ; Ceylan, Onur ; Suer, Ilknur ; Kaya, Murat ; Ittmann, Michael ; Karatas, Omer Faruk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>13/106</topic><topic>38/1</topic><topic>38/109</topic><topic>631/67/68</topic><topic>692/699/67/68</topic><topic>82</topic><topic>82/80</topic><topic>96</topic><topic>96/63</topic><topic>AKT protein</topic><topic>Analysis</topic><topic>Apoptosis</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Cell Proliferation</topic><topic>Colonies</topic><topic>Developed countries</topic><topic>Development and progression</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Genes</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Male</topic><topic>Malignancy</topic><topic>MicroRNAs - genetics</topic><topic>Molecular modelling</topic><topic>Phenotypes</topic><topic>Prognosis</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Receptor, IGF Type 1 - genetics</topic><topic>Receptor, IGF Type 1 - metabolism</topic><topic>Reproductive Medicine</topic><topic>RNA, Long Noncoding - genetics</topic><topic>Signal transduction</topic><topic>Signaling</topic><topic>Therapeutic targets</topic><topic>TOR protein</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Capik, Ozel</creatorcontrib><creatorcontrib>Sanli, Fatma</creatorcontrib><creatorcontrib>Kurt, Ali</creatorcontrib><creatorcontrib>Ceylan, Onur</creatorcontrib><creatorcontrib>Suer, Ilknur</creatorcontrib><creatorcontrib>Kaya, Murat</creatorcontrib><creatorcontrib>Ittmann, Michael</creatorcontrib><creatorcontrib>Karatas, Omer Faruk</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Prostate cancer and prostatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Capik, Ozel</au><au>Sanli, Fatma</au><au>Kurt, Ali</au><au>Ceylan, Onur</au><au>Suer, Ilknur</au><au>Kaya, Murat</au><au>Ittmann, Michael</au><au>Karatas, Omer Faruk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis</atitle><jtitle>Prostate cancer and prostatic diseases</jtitle><stitle>Prostate Cancer Prostatic Dis</stitle><addtitle>Prostate Cancer Prostatic Dis</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>24</volume><issue>3</issue><spage>891</spage><epage>902</epage><pages>891-902</pages><issn>1365-7852</issn><eissn>1476-5608</eissn><abstract>Background Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries. Investigation of the underlying molecular mechanisms of PCa is urgently needed in order to develop better therapeutic strategies and to reveal more effective therapeutic targets. In this study, we aimed at exploring the potential functions of CASC11 in association with miR-145 and IGF1R during the malignant progression of PCa cells. Methods We initially investigated the oncogenic potential of noncoding members of CASC gene family and analyzed the effects of CASC11 overexpression on proliferation, migration, and colony formation ability of DU145, LNCaP, and PC3 PCa cells. We, then, exprlored the association of CASC11, miR-145, and IGF1R expression and their impacts on PI3K/AKT/mTOR signaling pathway in in vitro models. Results In silico analysis revealed that of the CASC family only CASC11 showed consistent results considering its differential expression as well as its association with the overall survival of patients. We demonstrated that ectopic overexpression of CASC11 significantly increased the proliferation, colony formation, and migration capacity in all three cell lines. CASC11 overexpression caused suppression of miR-145 and overexpression of IGF1R, leading to activation of PI3K/AKT/mTOR signaling pathway. Conclusion In summary, we found that CASC11 is upregulated in PCa cells and clinical tumor samples in comparison to corresponding controls and revealed that ectopic CASC11 overexpression promotes cellular phenotypes associated with PCa progression through CASC11/miR-145/IGF1R axis.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>33753875</pmid><doi>10.1038/s41391-021-00353-0</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-0379-2088</orcidid><orcidid>https://orcid.org/0000-0003-4802-0978</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1365-7852
ispartof Prostate cancer and prostatic diseases, 2021-09, Vol.24 (3), p.891-902
issn 1365-7852
1476-5608
language eng
recordid cdi_proquest_miscellaneous_2504351979
source Springer Nature
subjects 1-Phosphatidylinositol 3-kinase
13/106
38/1
38/109
631/67/68
692/699/67/68
82
82/80
96
96/63
AKT protein
Analysis
Apoptosis
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cell Proliferation
Colonies
Developed countries
Development and progression
Gene Expression Regulation, Neoplastic
Genes
Health aspects
Humans
Lung cancer
Male
Malignancy
MicroRNAs - genetics
Molecular modelling
Phenotypes
Prognosis
Prostate cancer
Prostatic Neoplasms - genetics
Prostatic Neoplasms - metabolism
Prostatic Neoplasms - pathology
Receptor, IGF Type 1 - genetics
Receptor, IGF Type 1 - metabolism
Reproductive Medicine
RNA, Long Noncoding - genetics
Signal transduction
Signaling
Therapeutic targets
TOR protein
Tumor Cells, Cultured
title CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T16%3A46%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CASC11%20promotes%20aggressiveness%20of%20prostate%20cancer%20cells%20through%20miR-145/IGF1R%20axis&rft.jtitle=Prostate%20cancer%20and%20prostatic%20diseases&rft.au=Capik,%20Ozel&rft.date=2021-09-01&rft.volume=24&rft.issue=3&rft.spage=891&rft.epage=902&rft.pages=891-902&rft.issn=1365-7852&rft.eissn=1476-5608&rft_id=info:doi/10.1038/s41391-021-00353-0&rft_dat=%3Cgale_proqu%3EA673073115%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c473t-3acdffb6727c79065e0a54dca61fea25327aa878cb21ebbbe81be8e2560916653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2563936438&rft_id=info:pmid/33753875&rft_galeid=A673073115&rfr_iscdi=true